凯瑟普辛B响应型编程大脑向输送系统用于质母细胞瘤化学免疫疗法组合疗法
Shaoping Jiang1, Wenpei Li1, Jun Yang1
1School of Life Science, Advanced Research Institute of Multidisciplinary Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology, Beijing 100081, China.
一种新的脑向传递系统 (D&R-HM-MCA) 有效向多种质母细胞瘤 (GBM) 和瘤相关巨细胞 (TAM). 该系统通过克服血脑屏障并重新编程TAM来改善GBM治疗,从而增强化疗免疫疗法.
科学领域:
- 神经瘤学神经瘤学
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
背景情况:
- 与瘤相关的巨细胞 (TAMs) 驱动着多种质母细胞瘤 (GBM) 的进展和化学抵抗.
- 血脑屏障 (BBB) 阻碍了有效的GBM治疗.
- 精确准GBM细胞和TAM仍然是一个挑战.
研究的目的:
- 开发一种响应cathepsin B (CTSB) 的,针对大脑的输送系统 (D&R-HM-MCA),用于同时针对GBM和TAM.
- 通过克服BBB的局限性和调节瘤微环境,提高针对GBM的化疗免疫疗法的疗效.
主要方法:
- D&R-HM-MCA利用低密度脂蛋白受体相关蛋白1 (LRP1) 介导的细胞转移来穿越BBB.
- 响应CTSB的裂释放了angiopep-2,防止了排泄,并暴露了曼诺斯 (MAN) 以准GBM上的葡萄糖载体-1 (GLUT1) 和TAM上的巨类曼诺斯受体 (MMR).
- 该系统提供化疗药物,并诱导TAM极化从M2到M1表型.
主要成果:
- 成功透BBB并对GBM和TAM进行双重准.
- 诱导TAM偏向向一种促炎M1表型.
- 增强化学疗法杀死GBM和改善抗GBM免疫反应.
- 对抗GBM的联合化疗-免疫疗法的潜力已被证明.
结论:
- 响应CTSB的D&R-HM-MCA系统提高了用于GBM治疗的大脑输送效率.
- 这种方法可以通过向GBM细胞和重编程TAM来实现有效的化疗免疫疗法.
- 该战略为设计针对大脑的先进传递系统和GBM的治疗方案提供了一个有前途的框架.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
